Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed

Pulmonary arterial hypertension (PAH) is a serious complication of systemic sclerosis (SSc). In clinical trials PAH-SSc has been grouped with other forms, including idiopathic PAH. The primary endpoint for most pivotal studies was improvement in exercise capacity. However, composite clinical endpoin...

Descripción completa

Detalles Bibliográficos
Autores principales: Denton, Christopher P, Avouac, Jerome, Behrens, Frank, Furst, Daniel E, Foeldvari, Ivan, Humbert, Marc, Huscher, Doerte, Kowal-Bielecka, Otylia, Matucci-Cerinic, Marco, Nash, Peter, Opitz, Christian F, Pittrow, David, Rubin, Lewis J, Seibold, James R, Distler, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218892/
https://www.ncbi.nlm.nih.gov/pubmed/21699746
http://dx.doi.org/10.1186/ar3346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218892/
https://www.ncbi.nlm.nih.gov/pubmed/21699746
http://dx.doi.org/10.1186/ar3346

Ejemplares similares